Abstract:A beta(1-42) is the proteolytic cleavage product of cleavage of the amyloid precursor protein by beta- and gamma- secretases. The aggregation of A beta(1-42) plays a causative role in the development of Alzheimer's disease. To lock A beta(1-42) in a homogenous state, we embedded the A beta(1-42) sequence in an unstructured region of Bcl-x(L). Both the N-terminus and the C-terminus of A beta(1-42) were constrained in the disordered region, whereas the conjunction did not introduce any folding to A beta(1-42) but maintained the sequence as a monomer in solution. With Bcl-x(L)-A beta(42), we developed an enzyme-linked immunosorbent assay to compare the affinity of compounds for monomeric A beta(1-42). Bcl-x(L)-A beta(42) was coated on a microplate and this was followed by incubation with different concentrations of compounds. Compounds binding to Leu17-Val24 of A beta(1-42) inhibited the interaction between Bcl-x(L)-A beta(42) and antibody 4G8. The method can not only reproduce the activities of the reported A beta(1-42) inhibitors such as dopamine, tannin, and morin but can also differentiate decoy compounds that do not bind to A beta(1-42). Remarkably, using this method, we discovered a new inhibitor that binds to monomeric A beta(1-42) and inhibits A beta(1-42) fibril formation. As the structure of Bcl-x(L)-A beta(42) monomer is stable in solution, the assay could be adapted for high-throughput screening with a series of antibodies that bind the different epitopes of A beta(1-42). In addition, the monomeric form of the A beta(1-42) sequence in Bcl-x(L)-A beta(42) would also facilitate the identification of A beta(1-42) binding partners by coimmunoprecipitation, cocrystallization, surface plasmon resonance technology, or the assay as described here.

Computational investigation of the binding of a designed peptide to λ light chain amyloid fibril

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

Computational Design of Peptide-Au Cluster Probe for Sensitive Detection of Α(iib)β3 Integrin.

De novo Design of Peptides that Bind Specific Conformers of α-Synuclein

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Structure and Energetic Basis of Overrepresented Λ Light Chain in Systemic Light Chain Amyloidosis Patients.

Amyloid β (1–42) Folding Multiplicity and Single-Molecule Binding Behavior Studied with STM

Design of amyloidogenic peptide traps

Capturing the Conformational Heterogeneity of the Β-Amyloid Peptide Sequence Using the Engineered Aerolysin Confinement

Structural mechanism for specific binding of chemical compounds to amyloid fibrils

Detection and disaggregation of amyloid fibrils by luminescent amphiphilic platinum(II) complexes

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface

In Silico Study of Recognition Between Aβ40 and Aβ40 Fibril Surfaces: an N-Terminal Helical Recognition Motif and Its Implications for Inhibitor Design

Insight Into The Stability Of Cross-Beta Amyloid Fibril From Vealyl Short Peptide With Molecular Dynamics Simulation

Polyallylamine Binds to Aβ Amyloid and Inhibits Antibody Recognition

Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands.

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.